234 related articles for article (PubMed ID: 16790733)
1. Determination of the prevalence of drug misuse by meconium analysis.
Williamson S; Jackson L; Skeoch C; Azzim G; Anderson R
Arch Dis Child Fetal Neonatal Ed; 2006 Jul; 91(4):F291-2. PubMed ID: 16790733
[TBL] [Abstract][Full Text] [Related]
2. Multiple birth concordance of street drug assays of meconium analysis.
Lewis D; Moore C; Leikin JB; Kechavarz L
Vet Hum Toxicol; 1995 Aug; 37(4):318-9. PubMed ID: 8540217
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of gestational exposure to cannabis in a Mediterranean city by meconium analysis.
Lozano J; García-Algar O; Marchei E; Vall O; Monleon T; Giovannandrea RD; Pichini S
Acta Paediatr; 2007 Dec; 96(12):1734-7. PubMed ID: 17953730
[TBL] [Abstract][Full Text] [Related]
4. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy.
Wingert WE; Feldman MS; Kim MH; Noble L; Hand I; Yoon JJ
J Forensic Sci; 1994 Jan; 39(1):150-8. PubMed ID: 8113697
[TBL] [Abstract][Full Text] [Related]
5. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis.
Ostrea EM; Knapp DK; Tannenbaum L; Ostrea AR; Romero A; Salari V; Ager J
J Pediatr; 2001 Mar; 138(3):344-8. PubMed ID: 11241040
[TBL] [Abstract][Full Text] [Related]
6. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study.
Ostrea EM; Brady M; Gause S; Raymundo AL; Stevens M
Pediatrics; 1992 Jan; 89(1):107-13. PubMed ID: 1727992
[TBL] [Abstract][Full Text] [Related]
7. Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews.
Bibb KW; Stewart DL; Walker JR; Cook VD; Wagener RE
J Perinatol; 1995; 15(3):199-202. PubMed ID: 7666268
[TBL] [Abstract][Full Text] [Related]
8. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report.
Lester BM; ElSohly M; Wright LL; Smeriglio VL; Verter J; Bauer CR; Shankaran S; Bada HS; Walls HH; Huestis MA; Finnegan LP; Maza PL
Pediatrics; 2001 Feb; 107(2):309-17. PubMed ID: 11158464
[TBL] [Abstract][Full Text] [Related]
9. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium.
Montgomery D; Plate C; Alder SC; Jones M; Jones J; Christensen RD
J Perinatol; 2006 Jan; 26(1):11-4. PubMed ID: 16281047
[TBL] [Abstract][Full Text] [Related]
10. Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health.
Koren G; Hutson J; Gareri J
Clin Pharmacol Ther; 2008 Apr; 83(4):631-4. PubMed ID: 18288086
[TBL] [Abstract][Full Text] [Related]
11. Heavy in utero ethanol exposure is associated with the use of other drugs of abuse in a high-risk population.
Shor S; Nulman I; Kulaga V; Koren G
Alcohol; 2010; 44(7-8):623-7. PubMed ID: 20031369
[TBL] [Abstract][Full Text] [Related]
12. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project".
Pichini S; Puig C; Zuccaro P; Marchei E; Pellegrini M; Murillo J; Vall O; Pacifici R; García-Algar O
Forensic Sci Int; 2005 Oct; 153(1):59-65. PubMed ID: 15923097
[TBL] [Abstract][Full Text] [Related]
13. Substance use in pregnancy at the Mt. Hope Women's Hospital in Trinidad.
Ali Z; Davis G; Simmons V; Ramroop R
J Trop Pediatr; 2012 Aug; 58(4):328-9. PubMed ID: 21940740
[No Abstract] [Full Text] [Related]
14. Detection of cocaine exposure in the neonate. Analyses of urine, meconium, and amniotic fluid from mothers and infants exposed to cocaine.
Casanova OQ; Lombardero N; Behnke M; Eyler FD; Conlon M; Bertholf RL
Arch Pathol Lab Med; 1994 Oct; 118(10):988-93. PubMed ID: 7944901
[TBL] [Abstract][Full Text] [Related]
15. Alarming prevalence of fetal alcohol exposure in a Mediterranean city.
Garcia-Algar O; Kulaga V; Gareri J; Koren G; Vall O; Zuccaro P; Pacifici R; Pichini S
Ther Drug Monit; 2008 Apr; 30(2):249-54. PubMed ID: 18367990
[TBL] [Abstract][Full Text] [Related]
16. In utero drugs of abuse exposure testing for newborn twins.
Wang P; Molina CP; Maldonado JE; Bernard DW
J Clin Pathol; 2010 Mar; 63(3):259-61. PubMed ID: 20203227
[TBL] [Abstract][Full Text] [Related]
17. Targeted perinatal drug screening in a rural population.
O'Connor TA; Bondurant HH; Siddiqui J
J Matern Fetal Med; 1997; 6(2):108-10. PubMed ID: 9086427
[TBL] [Abstract][Full Text] [Related]
18. Confirmation of cannabinoids in meconium using two-dimensional gas chromatography with mass spectrometry detection.
Marin SJ; Coles R; Urry FM; McMillin GA
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):59-64. PubMed ID: 17881300
[TBL] [Abstract][Full Text] [Related]
19. [Prenatal exposure to drugs of abuse using meconium analysis in a low socioeconomic population in Barcelona].
García-Algar O; Vall Combelles O; Puig Sola C; Mur Sierra A; Scaravelli G; Pacifici R; Monleón Getino T; Pichini S
An Pediatr (Barc); 2009 Feb; 70(2):151-8. PubMed ID: 19217571
[TBL] [Abstract][Full Text] [Related]
20. Meconium drug screening to detect prenatal substance abuse.
Wildman KM; Mohl V; Houston R; Allerheiligen D
J Fam Pract; 1996 Nov; 43(5):501-2. PubMed ID: 8917151
[No Abstract] [Full Text] [Related]
[Next] [New Search]
